You are here

  • Home
  • Archive
  • Volume 1, Issue 1
  • 002 Treatment of wide necked intracranial aneurysms using the Enterprise stent: mid-term clinical and angiographic results

Article Text

Article menu
Download PDFPDF
SNIS Annual Meeting oral abstracts
002 Treatment of wide necked intracranial aneurysms using the Enterprise stent: mid-term clinical and angiographic results
  1. M DeLeo III,
  2. M Gounis,
  3. A Wakhloo
  1. University of Massachusetts Medical School, Worcester,, Massachusetts, USA

https://doi.org/10.1136/jnis.2009.000851b

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Purpose: Stent assisted coiling techniques have improved the endovascular treatment of wide necked (neck >4 mm or dome-to-neck ratio <2) saccular and fusiform/dissecting intracranial aneurysms. The Enterprise stent (Cordis Endovascular; Miami Lakes, Florida, USA) is the first commercially available closed cell nitinol stent approved for the treatment of wide necked intracranial aneurysms in the USA. Here we seek to evaluate the safety and efficacy of the Enterprise stent in the treatment of such aneurysms.

    Materials and Methods: Between June 2007 and March 2009, 56 wide necked saccular and fusiform/dissecting intracranial aneurysms in 52 patients were treated endovascularly using the Enterprise stent. The aneurysms were in …

    View Full Text